Bladder cancer end of life care
Pro Research Analysisby 
Searched over 200M research papers
Prevalence of Aggressive and High-Intensity End-of-Life Care in Bladder Cancer
Aggressive end-of-life care is common among patients dying from bladder cancer. Over half of Medicare beneficiaries with bladder cancer receive aggressive interventions in the last month of life, such as multiple hospital admissions, emergency department visits, intensive care unit stays, late chemotherapy, or dying in an acute-care hospital. In-hospital death is the most frequent, affecting about 30% of patients, while 28% are admitted to the ICU and 17% have more than one emergency visit in their final month 12. These high-intensity care patterns are often not aligned with patient preferences and are associated with poorer outcomes 12.
Hospice Enrollment and Its Impact on End-of-Life Care Quality
Hospice care is known to improve quality of life for patients nearing the end of life, but bladder cancer patients have some of the lowest hospice enrollment rates among cancer patients. However, hospice use has increased over time, with 55% of patients enrolled at the time of death and rates rising from about 50% in 2004 to 72% in 2015 . Patients who enroll in hospice tend to be older, white, married, and have fewer other health problems. Importantly, those who spend more than 30 days in hospice meet more quality indicators for end-of-life care and have less high-intensity healthcare use in their final month . Despite these benefits, the median hospice enrollment is short—just 13 days before death .
Trends and Disparities in Place of Death and Hospice Utilization
Home is now the most common place of death for bladder cancer patients in the United States, accounting for about 42% of deaths, followed by medical facilities, nursing homes, and hospice facilities. Hospice and home-based end-of-life care have become more prominent over the past two decades, but significant disparities remain. Black patients are less likely to use hospice than white patients, and regional differences persist, with the South having the highest proportion of bladder cancer deaths . The COVID-19 pandemic further increased the proportion of deaths occurring at home or in hospice, with fewer in medical facilities .
Palliative Care and Timing
Palliative care is underutilized and often initiated very close to death for bladder cancer patients. Even among those receiving high-intensity end-of-life care, palliative care is typically started late, limiting its potential benefits . Early and longer engagement with palliative or hospice care is associated with better quality of life and reduced aggressive interventions at the end of life 24.
Quality of Life and Supportive Care Needs
Bladder cancer and its treatments can significantly affect quality of life, especially in the end-of-life phase. Patients often experience problems with urinary, sexual, and bowel function, as well as challenges with daily activities and emotional well-being 89. Comprehensive care—including physical, nutritional, and psychosocial support—can help address these issues and improve patient comfort and satisfaction in their final months 789.
Economic Considerations
End-of-life care for bladder cancer is costly, especially when aggressive interventions are used. Reducing unnecessary hospitalizations and focusing on effective palliative and hospice care can help lower costs while improving patient outcomes .
Conclusion
End-of-life care for bladder cancer patients is often marked by high-intensity, aggressive interventions, but trends show increasing use of hospice and home-based care. Early and sustained hospice or palliative care improves quality of life and reduces unnecessary interventions. However, disparities in access and timing of care persist, highlighting the need for more equitable and patient-centered end-of-life strategies for all bladder cancer patients 1234.
Sources and full results
Most relevant research papers on this topic